The rising prevalence of autonomic dysreflexia (AD) and the approval of a vasopressin drug are projected to fuel growth in the worldwide vasopressin market. Complications from vasopressin usage, such as asthma, epilepsy, heart disease, and heart failure, are likely to be the key factors impeding the growth of the worldwide vasopressin market. The recent increase in the number of persons suffering from Novel Corona virus is predicted to result in an increase in cardiac syndrome. As a result, the pharmaceutical industry is focusing on research and development of enhanced vasopressin medications for therapy reasons. This is projected to drive worldwide market growth in the near future.
According to Coherent Market Insights, the global Vasopressin Market is estimated to be valued at US$ 1,112.6 million in 2021 and is expected to exhibit a CAGR of 14.7% over the forecast period (2021-2028).
Top Companies in the Vasopressin Industry:
Par Pharmaceutical
Founded in 1978, Par is a manufacturer and distributor of injectable products and branded drugs, headquartered in the United States. The company develops, manufactures and markets sterile injectables, alternative dosage forms and many other differentiated products and forming alliances with major pharmaceutical companies, specialty drug delivery companies and other product and service providers.
Pfizer Inc.
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide.
Novartis AG
The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. In January 2020, Novartis AG announced that it had completed acquisition of The Medicines Company, a pharmaceutical company
Ferring Pharmaceuticals
Headquartered in Switzerland. The founded in 1980. Ferring is research-driven, especially biopharmaceutical group committed to helping people build healthy families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.
Fresenius Kabi Canada
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Kabi completes majority stake acquisition of mAbxience holding S.L., significantly enhancing presence in high-growth biopharmaceuticals market on August 1, 2022.